Welcome to CDC Stacks | A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation - 13405 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation
  • Published Date:
    Apr 11 2013
  • Source:
    PLoS Negl Trop Dis. 2013; 7(4).
Filetype[PDF - 566.97 KB]


No Related Documents.
You May Also Like:
  1. Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation
    Personal Author:
    Chu, Brian K.; Deming, Michael; Biritwum, Nana-Kwadwo; Bougma, Windtaré R.; Dorkenoo, Améyo M.; El-Setouhy, Maged; Fischer, Peter U.; Gass, Katherine; Gonzalez de Peña, Manuel; Mercado-Hernandez, Leda; Kyelem, Dominique; Lammie, Patrick J.; Flueckiger, Rebecca M.; Mwingira, Upendo J.; Noordin, Rahmah; Offei Owusu, Irene; Ottesen, Eric A.; Pavluck, Alexandre; Pilotte, Nils; Rao, Ramakrishna U.; Samarasekera, Dilhani; Schmaedick, Mark A.; Settinayake, Sunil; Simonsen, Paul E.; Supali, Taniawati; Taleo, Fasihah; Torres, Melissa; Weil, Gary J.; Won, Kimberly Y.;
    Published:
    Dec 05 2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(12).
    Description:
    Background : Lymphatic filariasis (LF) is targeted for global elimination through treatment of entire at-risk populations with repeated annual mass drug administration (MDA). Essential for program success is defining and confirming the appropriate en...
    File Type:
    Filetype[PDF - 206.40 KB]
  2. Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
    Personal Author:
    Ichimori, Kazuyo; King, Jonathan D.; Engels, Dirk; Yajima, Aya; Mikhailov, Alexei; Lammie, Patrick; Ottesen, Eric A.;
    Published:
    Dec 11 2014
    Source:
    PLoS Negl Trop Dis. 2014; 8(12).
    File Type:
    Filetype[PDF - 1.01 MB]
  3. Increasing Compliance with Mass Drug Administration Programs for Lymphatic Filariasis in India through Education and Lymphedema Management Programs
    Personal Author:
    Cantey, Paul T.; Rout, Jonathan; Rao, Grace; Williamson, John; Fox, LeAnne M.;
    Published:
    Jun 29 2010
    Source:
    PLoS Negl Trop Dis. 4(6).
    Description:
    Background : Nearly 45% of people living at risk for lymphatic filariasis (LF) worldwide live in India. India has faced challenges obtaining the needed levels of compliance with its mass drug administration (MDA) program to interrupt LF transmission,...
    File Type:
    Filetype[PDF - 115.07 KB]
  4. Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature
    Personal Author:
    Addiss, David G; Brady, Molly A;
    Published:
    Feb 15 2007
    Source:
    Filaria J. 2007; 6:2.
    Description:
    The Global Programme to Eliminate Lymphatic Filariasis (GPELF) has two major goals: to interrupt transmission of the parasite and to provide care for those who suffer the devastating clinical manifestations of the disease (morbidity control). This la...
    File Type:
    Filetype[PDF - 557.29 KB]
  5. Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
    Personal Author:
    Schmaedick, Mark A.; Koppel, Amanda L.; Pilotte, Nils; Torres, Melissa; Williams, Steven A.; Dobson, Stephen L.; Lammie, Patrick J.; Won, Kimberly Y.;
    Published:
    Aug 14 2014
    Source:
    PLoS Negl Trop Dis. 2014; 8(8).
    Description:
    Background : Mass drug administration (MDA) programs have dramatically reduced lymphatic filariasis (LF) incidence in many areas around the globe, including American Samoa. As infection rates decline and MDA programs end, efficient and sensitive meth...
    File Type:
    Filetype[PDF - 1.07 MB]